ANGLE plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Andrew Newland, was filed 19 Jul 2022.
ANGLE plc: what insiders have been doing
Every trade that managers of ANGLE plc disclose to RNS (LSE) is tracked on this page. Nothing new has been filed by managers of ANGLE plc in twelve months, the latest record being from 19 July 2022.
Over the whole record (from 2020), the tally stands at 4 purchases and no sales.
Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -80.7%Entry £0.78 · Close at T+365 £0.15
- -80.7%Entry £0.78 · Close at T+365 £0.15
- +162.3%Entry £0.46 · Close at T+365 £1.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 37,500 shares@ £0.8070.2% of flowOff MarketISIN GB0034330679FCA-NSM:4444867-1Canonical exit: 17 Oct 2022 (T+90)
- 125,000 shares@ £0.80100.0% of flowOff marketISIN GB0034330679FCA-NSM:4444867-0Canonical exit: 17 Oct 2022 (T+90)
- 30,000 shares@ £0.447529.8% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB0034330679FCA-NSM:3768715-0Canonical exit: 31 Jan 2021 (T+90)
- 30,000 shares@ £0.45100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB0034330679FCA-NSM:3768715-1Canonical exit: 31 Jan 2021 (T+90)
4 of 4 declarations
About ANGLE plc
ANGLE plc is a UK-based company focused on developing technologies for cancer diagnostics. It specializes in the use of circulating tumor cell technology to enhance cancer screening and treatment.
